| Constance Avery-clark, PHD | |
|
1890 N University Drive, Suite 215, Coral Springs, FL 33071 | |
| (954) 227-2700 | |
| (954) 227-2704 |
| Full Name | Constance Avery-clark |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Clinical |
| Location | 1890 N University Drive, Coral Springs, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033215231 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PY0003980 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Constance Avery-clark, PHD 1890 N University Drive, Suite 215, Coral Springs, FL 33071 Ph: (954) 227-2700 | Constance Avery-clark, PHD 1890 N University Drive, Suite 215, Coral Springs, FL 33071 Ph: (954) 227-2700 |
News Archive
Human Genome Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the resubmission of the Biologics License Application (BLA) for raxibacumab, a treatment for inhalational anthrax, and has established December 15, 2012 as the Prescription Drug User Fee Act (PDUFA) action date.
A new web-based community portal, http://www.MyApnea.Org, is recruiting patients, caregivers and those at risk for sleep apnea to join a growing community of patients and researchers to better understand sleep apnea through information sharing, support and research.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, today announced the presentation of preclinical research describing the mechanism of action of otelixizumab at the 46th Annual Meeting of the European Association for the Study of Diabetes (EASD). In addition, Tolerx also announced that the first European patient was enrolled in DEFEND-2, a confirmatory Phase 3 clinical trial evaluating otelixizumab in autoimmune new-onset type 1 diabetes.
In a recent bioRxiv* preprint paper, researchers isolated anti-RBD nanobodies from llamas and "nanomice" (they engineered to produce VHHs cloned from alpacas, dromedaries and camels).
› Verified 7 days ago
Dr. Robert L Wernick, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1881 N University Dr, Ste 104, Coral Springs, FL 33071 Phone: 954-340-0888 Fax: 954-346-0909 | |
Adam Feder, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 5451 North University Dr, Suite 102, Coral Springs, FL 33067 Phone: 305-962-0274 Fax: 305-653-4551 | |
Dr. Meriam Mikhail, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1881 N University Dr, Coral Springs, FL 33071 Phone: 954-340-0888 | |
Jon Goldblatt, LMHC, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 807 Coral Ridge Dr, Coral Springs, FL 33071 Phone: 954-755-0909 | |
Stephanie Smith, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 7451 Wiles Rd Ste 103, Coral Springs, FL 33067 Phone: 954-340-0888 | |
Dr. Felicia Ann Tralongo, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1890 N University Dr, Suite 215, Coral Springs, FL 33071 Phone: 954-227-2700 |